These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 28941978)

  • 1. Barriers to accessing abortion services and perspectives on using mifepristone and misoprostol at home in Great Britain.
    Aiken ARA; Guthrie KA; Schellekens M; Trussell J; Gomperts R
    Contraception; 2018 Feb; 97(2):177-183. PubMed ID: 28941978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors Associated With Use of an Online Telemedicine Service to Access Self-managed Medical Abortion in the US.
    Aiken ARA; Starling JE; Gomperts R
    JAMA Netw Open; 2021 May; 4(5):e2111852. PubMed ID: 34019085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Women's experiences of a telemedicine abortion service (up to 12 weeks) implemented during the coronavirus (COVID-19) pandemic: a qualitative evaluation.
    Boydell N; Reynolds-Wright JJ; Cameron ST; Harden J
    BJOG; 2021 Oct; 128(11):1752-1761. PubMed ID: 34138505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Motivations for using misoprostol for abortion outside the formal healthcare system in Colombia: a qualitative study of women seeking postabortion care in Bogotá and the Coffee Axis.
    Ortiz J; Blades N; Prada E
    Reprod Health; 2024 Jun; 21(1):76. PubMed ID: 38824533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical abortion with mifepristone and home administration of misoprostol up to 63 days' gestation.
    Løkeland M; Iversen OE; Engeland A; Økland I; Bjørge L
    Acta Obstet Gynecol Scand; 2014 Jul; 93(7):647-53. PubMed ID: 24766569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Home self-administration of vaginal misoprostol for medical abortion at 50-63 days compared with gestation of below 50 days.
    Kopp Kallner H; Fiala C; Stephansson O; Gemzell-Danielsson K
    Hum Reprod; 2010 May; 25(5):1153-7. PubMed ID: 20172871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementing medical abortion with mifepristone and misoprostol in Norway 1998-2013.
    Løkeland M; Bjørge T; Iversen OE; Akerkar R; Bjørge L
    Int J Epidemiol; 2017 Apr; 46(2):643-651. PubMed ID: 28031316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-depth interviews with medical abortion clients: thoughts on the method and home administration of misoprostol.
    Elul B; Pearlman E; Sorhaindo A; Simonds W; Westhoff C
    J Am Med Womens Assoc (1972); 2000; 55(3 Suppl):169-72. PubMed ID: 10846331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mifepristone-misoprostol medical abortion: home administration of misoprostol in Guadeloupe.
    Guengant JP; Bangou J; Elul B; Ellertson C
    Contraception; 1999 Sep; 60(3):167-72. PubMed ID: 10640161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose mifepristone 200 mg and vaginal misoprostol for abortion.
    Schaff EA; Eisinger SH; Stadalius LS; Franks P; Gore BZ; Poppema S
    Contraception; 1999 Jan; 59(1):1-6. PubMed ID: 10342079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "I'll just deal with this on my own": a qualitative exploration of experiences with self-managed abortion in the United States.
    Raifman S; Ralph L; Biggs MA; Grossman D
    Reprod Health; 2021 May; 18(1):91. PubMed ID: 33947413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The efficacy and acceptability of mifepristone medical abortion with home administration misoprostol provided by private providers linked with the hospital: a prospective study of 433 patients].
    Faucher P; Baunot N; Madelenat P
    Gynecol Obstet Fertil; 2005 Apr; 33(4):220-7. PubMed ID: 15894206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acceptability and feasibility of the use of 400 μg of sublingual misoprostol after mifepristone for medical abortion up to 63 days since the last menstrual period: evidence from Uzbekistan.
    Raghavan S; Tsereteli T; Kamilov A; Kurbanbekova D; Yusupov D; Kasimova F; Jymagylova D; Winikoff B
    Eur J Contracept Reprod Health Care; 2013 Apr; 18(2):104-11. PubMed ID: 23387475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acceptability and feasibility of medical abortion with mifepristone and misoprostol in Nigeria.
    Okonofua F; Shittu O; Shochet T; Diop A; Winikoff B
    Int J Gynaecol Obstet; 2014 Apr; 125(1):49-52. PubMed ID: 24507887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-management of first trimester medical termination of pregnancy: a qualitative study of women's experiences.
    Purcell C; Cameron S; Lawton J; Glasier A; Harden J
    BJOG; 2017 Dec; 124(13):2001-2008. PubMed ID: 28421651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility of a hospital outpatient day procedure for medication abortion at 13-18 weeks gestation: Findings from Nepal
    Blum J; Karki C; Tamang A; Shochet T; Shrestha A; Tuladhar H; Karki A; Sharma J; Abbas DF; Dragoman M; Winikoff B
    Contraception; 2019 Dec; 100(6):451-456. PubMed ID: 31491379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Women's abortion seeking behavior under restrictive abortion laws in Mexico.
    Juarez F; Bankole A; Palma JL
    PLoS One; 2019; 14(12):e0226522. PubMed ID: 31881041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self reported outcomes and adverse events after medical abortion through online telemedicine: population based study in the Republic of Ireland and Northern Ireland.
    Aiken ARA; Digol I; Trussell J; Gomperts R
    BMJ; 2017 May; 357():j2011. PubMed ID: 28512085
    [No Abstract]   [Full Text] [Related]  

  • 19. Acceptability and feasibility of mifepristone medical abortion in the early first trimester in Azerbaijan.
    Louie KS; Tsereteli T; Chong E; Aliyeva F; Rzayeva G; Winikoff B
    Eur J Contracept Reprod Health Care; 2014 Dec; 19(6):457-64. PubMed ID: 25047120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Women's voices and medical abortions: A review of the literature.
    Alam B; Kaler A; Mumtaz Z
    Eur J Obstet Gynecol Reprod Biol; 2020 Jun; 249():21-31. PubMed ID: 32348948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.